Chief Executive Officer
“Genomics is an important way to change healthcare that is being underutilized today. I want to change that.”
Rob Brainin joined Genuity Science in August 2017 and served as COO until March 2018, when he was appointed CEO and Board Director. Before joining Genuity, Rob was Vice President and General Manager of Life Sciences and Applied Genomics at Illumina, having previously served as VP and Head of the Arrays Business. Rob has also held senior roles at Life Technologies, Invitrogen and Thermo Fisher. In all these roles, he led the expansion of the applications of technologies or genomic data to new fields to serve the needs of growing types of users.
He started his career as a management consultant at McKinsey & Company. He is passionate about Genuity Science’s mission of improving lives through genomics and addressing the big challenge that we are uniquely positioned to solve: how to turn genomic data into insights that can help people to live better, healthier lives.
Rob holds an undergraduate degree in economics from Emory University and a law degree from Harvard Law School.